Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial

E-ISSN： 1741-203x|27|12|2059-2067

ISSN： 1041-6102

Source： International Psychogeriatrics, Vol.27, Iss.12, 2015-12, pp. : 2059-2067

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

International Psychogeriatrics, Vol. 25, Iss. 6, 2013-06 ,pp. : 919-927

Cambridge University Press

Access to resources Recommend Favorite

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

International Psychogeriatrics, Vol. 25, Iss. 5, 2013-05 ,pp. : 707-719

Cambridge University Press

Access to resources Recommend Favorite

Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design

International Psychogeriatrics, Vol. 27, Iss. 2, 2015-02 ,pp. : 181-197

Cambridge University Press

Access to resources Recommend Favorite

Developing medicines for agitation and aggression in Alzheimer's disease

International Psychogeriatrics, Vol. 27, Iss. 2, 2014-12 ,pp. : 179-179

Cambridge University Press

Access to resources Recommend Favorite

Bright light therapy for agitation in dementia: a randomized controlled trial

International Psychogeriatrics, Vol. 21, Iss. 4, 2009-08 ,pp. : 711-721

Cambridge University Press

Access to resources Recommend Favorite